![astellas_sign](https://pharmaphorum.com/wp-content/uploads/2022/10/astellas_sign.jpg)
Astellas makes another gene therapy play, takes stake in Tay...
Astellas has been having some safety-related issues with its gene therapy programmes of late, but it shows no signs of lessened enthusiasm for the category – as a new alliance with US biote